Entropy Neurodynamics
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 8 Oct 2026
- Reported shorts
- 6
- Shares on issue
- 1.634B
Entropy Neurodynamics (ENP) Short Interest
Entropy Neurodynamics (ASX:ENP) had 0.00% of shares reported as short positions as of 8 Oct 2026, representing 6 shares. Entropy Neurodynamics operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Entropy Neurodynamics
Entropy Neurodynamics is an Australian biotechnology company focused on developing novel therapies for neurological and psychiatric disorders. They leverage innovative approaches in drug development, aiming to address unmet needs in mental health and improve patient outcomes. The company is listed on the ASX and seeks to create value through its research and development pipeline.
Company profile →Entropy Neurodynamics (ASX:ENP) has 0.00% of its shares on issue reported as short positions as of 8 Oct 2026, or about 6 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. ENP is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads ENP today
- Zanger BreakoutWatchScore 38rank 264 of 1931
- CAN SLIMWatchScore 22rank 593 of 1541
- Minervini Trend TemplateWatchScore 55rank 257 of 1736
- Crowded-Short BreakoutWatchScore 11rank 828 of 1479
- Quality compoundersWatchScore 21rank 729 of 1677
Prices to 13 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
ENP fundamentals
In the year to 30 Jun 2026, Entropy Neurodynamics (ASX:ENP) recorded revenue of A$2.1M and a net loss after tax of A$4.9M. A year earlier it recorded revenue of A$1.6M and a net loss after tax of A$5.3M. Year-on-year growth: revenue +30.0% (FY). Net margin −235.9%, return on equity −73.1% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest ENP news
All news- Cleansing Notice
asx · 13 Oct 2026
- Application for quotation of securities - ENP
asx · 13 Oct 2026
- Change of Director's Interest Notice - HJ
asx · 13 Oct 2026
Company details
website
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss ENP
Start a research thread or post the first pulse update